Northern Trust Corp Cor Medix Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Cor Medix Inc. stock. As of the latest transaction made, Northern Trust Corp holds 567,233 shares of CRMD stock, worth $6.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

567,233

Previous 516,517 9.82%

Holding current value

$6.52 Million

Previous $3.18 Million 119.68%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$5.86 - $16.56 $297,195 - $839,856	50,716 Added 9.82%	567,233 $6.99 Million
Q1 2025 May 13, 2025	BUY	$6.16 - $12.57 $30,504 - $62,246	4,952 Added 0.97%	516,517 $3.18 Million
Q4 2024 Feb 14, 2025	BUY	$8.1 - $13.59 $520,368 - $873,062	64,243 Added 14.36%	511,565 $4.14 Million
Q3 2024 Nov 13, 2024	BUY	$3.64 - $8.23 $5,976 - $13,513	1,642 Added 0.37%	447,322 $3.61 Million
Q2 2024 Aug 14, 2024	SELL	$4.08 - $6.39 $52,827 - $82,737	-12,948 Reduced 2.82%	445,680 $1.93 Million
Q1 2024 May 14, 2024	BUY	$2.94 - $4.24 $28,435 - $41,009	9,672 Added 2.15%	458,628 $1.94 Million
Q4 2023 Feb 13, 2024	SELL	$3.0 - $4.01 $6,777 - $9,058	-2,259 Reduced 0.5%	448,956 $1.69 Million
Q3 2023 Nov 13, 2023	BUY	$3.6 - $4.46 $255,031 - $315,955	70,842 Added 18.62%	451,215 $1.67 Million
Q2 2023 Aug 11, 2023	BUY	$3.94 - $5.8 $1.19 Million - $1.75 Million	302,445 Added 388.11%	380,373 $1.51 Million
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $21,458 - $30,721	6,664 Added 9.35%	77,928 $322,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $2,786 - $7,429	988 Added 1.41%	71,264 $201,000
Q2 2022 Aug 12, 2022	SELL	$2.73 - $5.61 $691,402 - $1.42 Million	-253,261 Reduced 78.28%	70,276 $283,000
Q1 2022 May 13, 2022	SELL	$3.83 - $6.24 $47,591 - $77,538	-12,426 Reduced 3.7%	323,537 $1.77 Million
Q4 2021 Feb 08, 2022	SELL	$4.47 - $5.56 $32,519 - $40,449	-7,275 Reduced 2.12%	335,963 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $79,307 - $126,430	-17,782 Reduced 4.93%	343,238 $1.6 Million
Q2 2021 Aug 13, 2021	BUY	$6.05 - $10.09 $153,670 - $256,286	25,400 Added 7.57%	361,020 $2.48 Million
Q1 2021 May 12, 2021	SELL	$6.84 - $17.58 $116,355 - $299,053	-17,011 Reduced 4.82%	335,620 $3.35 Million
Q4 2020 Feb 11, 2021	BUY	$5.0 - $9.15 $72,700 - $133,041	14,540 Added 4.3%	352,631 $2.62 Million
Q3 2020 Nov 16, 2020	BUY	$3.96 - $6.15 $38,899 - $60,411	9,823 Added 2.99%	338,091 $2.04 Million
Q2 2020 Aug 14, 2020	BUY	$3.08 - $6.56 $25,000 - $53,247	8,117 Added 2.54%	328,268 $2.07 Million
Q1 2020 May 14, 2020	BUY	$2.35 - $7.08 $60,493 - $182,253	25,742 Added 8.74%	320,151 $1.15 Million
Q4 2019 Feb 14, 2020	SELL	$4.96 - $7.75 $84,419 - $131,905	-17,020 Reduced 5.47%	294,409 $2.14 Million
Q3 2019 Nov 13, 2019	BUY	$6.38 - $9.69 $1.33 Million - $2.02 Million	207,998 Added 201.1%	311,429 $1.99 Million
Q2 2019 Aug 13, 2019	BUY	$5.93 - $10.57 $348,701 - $621,547	58,803 Added 131.76%	103,431 $928,000
Q1 2019 May 13, 2019	BUY	$6.95 - $13.25 $310,164 - $591,321	44,628 New	44,628 $421,000

Others Institutions Holding CRMD

# of Institutions

183

Shares Held

32.6M

Call Options Held

881K

Put Options Held

583K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $474M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cor Medix Inc. Transaction History